18FDG-PET in epilepsies of infantile onset with pharmacoresistant generalised tonic-clonic seizures

Epilepsy Research

Volumn 60, Issue 1, 2004, Pages 53-61

  Korinthenberg, Rudolf ^a   Bauer Scheid, Carola ^a   Burkart, Peter ^b   Martens Le Bouar, Heike ^a   Kassubek, Jan ^a   Juengling, Freimut D ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b Epilepsy Center Kork   (Germany)

Author keywords

Childhood; Epilepsy; GTCS; Positron emission tomography; Severe myoclonic epilepsy of infancy

Indexed keywords

HYPOTONIC SOLUTION; ANTICONVULSIVE AGENT; DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ADOLESCENT; ARTICLE; ATAXIA; BRAIN INJURY; CHILD; CLINICAL EXAMINATION; CORRELATION ANALYSIS; ELECTROENCEPHALOGRAM; EPILEPSY; FEMALE; HUMAN; MALE; MENTAL DEFICIENCY; MUSCLE HYPOTONIA; MYOCLONUS SEIZURE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SEDATION; SPIKE WAVE; STATISTICAL PARAMETERS; TONIC CLONIC SEIZURE; BRAIN; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DRUG RESISTANCE; ELECTROENCEPHALOGRAPHY; GENERALIZED EPILEPSY; GRAND MAL EPILEPSY; HOSPITALIZATION; INFANT; METABOLISM; ONSET AGE; PATHOPHYSIOLOGY; PRESCHOOL CHILD; PSYCHOLOGICAL ASPECT; SCINTISCANNING;

ADOLESCENT; AGE OF ONSET; ANTICONVULSANTS; ATAXIA; BRAIN; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE; ELECTROENCEPHALOGRAPHY; EPILEPSY; EPILEPSY, GENERALIZED; EPILEPSY, TONIC-CLONIC; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; INFANT; MALE; MENTAL RETARDATION; MUSCLE HYPOTONIA; RADIOPHARMACEUTICALS; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 3242758948     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2004.05.006     Document Type: Article

References (30)

1. Abou Khalil B.W., Siegel G.J., Sackellares J.C., Gilman S., Hichwa R., Marshall R. Positron emission tomography studies of cerebral glucose metabolism in chronic partial epilepsy. Ann. Neurol. 22:1987;480-486
2. Benlounis A., Nabbout R., Feingold J., Parmeggiani A., Guerrini R., Kaminska A., Dulac O. Genetic predisposition to severe myoclonic epilepsy in infancy. Epilepsia. 42:2001;204-209
3. Chugani H.T., Phelps M.E., Mazziotta J.C. Positron emission tomography study of human brain functional development. Ann. Neurol. 22:1987a;487-497
4. Chugani H.T., Mazziotta J.C., Engel J., Phelps M.E. The Lennox-Gastaut syndrome: metabolic subtypes determined by 2-Deoxy-2{18F}fluoro-D-glucose positron emission tomography. Ann. Neurol. 21:1987b;4-13
5. Chugani H.T., Shewmon A., Shields W.D., Sankar R., Comair Y., Vinters H.V., Peacock W.J. Surgery for intractable infantile spasms: neuroimaging perspectives. Epilepsia. 34:1993;764-771
6. Chugani H.T., Conti J.R. Etiologic classification of infantile spasms in 140 cases: role of PET. J. Child Neurol. 11:1996;44-48
7. Doose H., Lunau H., Castiglione E., Waltz S. Severe idiopathic generalized epilepsy of infancy with generalized tonic-clonic seizures. Neuropediatrics. 29:1998;229-238
8. Dravet, C., Bureau, M., Guerrini, R., Giraud, N., Roge, J., 1992. Severe myoclonic epilepsy in infants. in: Roger, J., Bureau, M., Dravet, C., Dreifuss, F.E., Peret, A., Wolf, P. (Eds.), Epileptic Syndromes in Infancy, Childhood and Adolescence, second ed. John Libbey, London.
9. Drzezga A., Arnold S., Minoshima S., Noachtar S., Szecsi J., Winkler P., Romer W., Tatsch K., Weber W., Bartenstein P. 18F-FDG PET studies in patients with extratemporal and temporal epilepsy: evaluation of an observer-independent analysis. J. Nucl. Med. 40:1999;737-746
10. Duncan J.S. Positron emission tomography studies of cerebral blood flow and glucose metabolism. Epilepsia. 38(Suppl 10):1997;42-47
11. 18FDG PET in epileptic encephalopathies Arch. Dis. Child. 75:1996;102-107
12. Ferrie C.D., Madigan C., Tilling K., Maisey M.N., Marsden P.K., Robinson R.O. Adaptive and maladaptive behaviour in children with epileptic encephalopathies: correlation with cerebral glucose metabolism. Dev. Med. Child Neurol. 39:1997;588-595
13. Gur R.C., Sussman N.M., Alavi A., Gur R.E., Rosen A.D., O'Connor M., Goldberg H.I., Greenberg J.H., Reivich M. Positron emission tomography in two cases of childhood epileptic encephalopathy (Lennox-Gastaut syndrome). Neurology. 32:1982;1191-1194
14. Holmes, G.L., Stafstrom, C.E., 1997. Effects of seizures on the developing brain. in: Tuxhorn, I., Holthausen, H., Boenigk, H. (Eds.), Paediatric Epilepsy Syndromes and their Surgical Treatment. John Libbey, London.
15. Juengling F.D., Kassubek J., Martens-Le Bouar H., Reinhardt M.J., Krause T., Nitzsche E.U., Moser E., Korinthenberg R. Cerebral regional hypometabolism caused by propofol-induced sedation in children with severe myoclonic epilepsy: a study using fluorodeoxyglucose positron emission tomography and statistical parametric mapping. Neurosi. Lett. 335:2002;79-82
16. Lee N., Radtke R.A., Gray L., Burger P.C., Montine T.J., DeLong G.R., Lewis D.V., Oakes W.J., Friedman A.H., Hoffman J.M. Neuronal migration disorders: positron emission tomography correlations. Ann. Neurol. 35:1994;290-297
17. Maquet P., Hirsch E., Dive D., Salmon E., Marescaux C., Franck G. Cerebral glucose utilization during sleep in Landau-Kleffner syndrome: a PET study. Epilepsia. 31:1990;778-783
18. Muzik O., da Silva E.A., Juhasz C., Chugani D.C., Shah J., Nagy F., Canady A., von Stockhausen H.M., Herholz K., Gates J., Frost M., Ritter F., Watson C., Chugani H.T. Intracranial EEG versus flumazenil and glucose PET in children with extratemporal lobe epilepsy. Neurology. 54:2000;171-179
19. Ochs R.F., Gloor P., Tyler J.L., Wolfson T., Worsley K., Andermann F., Diksic M., Meyre E., Evans A. Effect of generalized spike-and-wave discharge on glucose metabolism measured by positron emission tomography. Ann. Neurol. 21:1987;458-464
20. Oguni H., Hayashi K., Oguni M., Mukahira A., Uehara T., Fukuyama Y., Umezu R., Izumi T., Hara M. Treatment of severe myoclonic epilepsy in infants with bromide and its borderline variant. Epilepsia. 35:1994;1140-1145
21. Olson D.M., Chugani H.T., Shewmon D.A., Phelps M.E., Peacock W.J. Electrocorticographic confirmation of focal positron emission tomographic abnormalities in children with intractable epilepsy. Epilepsia. 31:1990;731-739
22. Parker A.P.J., Ferrie C.D., Keevil S., Newbold M., Cox T., Maisey M., Robinson R.O. Neuroimaging and spectroscopy in children with epileptic encephalopathies. Arch. Dis. Child. 79:1998;39-43
23. Renier W.O., Renkawek K. Clinical and neuropathologic findings in a case of severe myoclonic epilepsy of infancy. Epilepsia. 31:1990;287-291
24. Savic I., Widen L., Thorell J.O., Blomqvist G., Ericson K., Roland P. Cortical benzodiazepine receptor binding in patients with generalized and partial epilepsy. Epilepsia. 31:1990;724-730
25. Signorini M., Paulesu E., Friston K., Perani D., Colleluori A., Lucignani G., Grassi F., Bettinardi V., Frackowiak R.S., Fazio F. Rapid assessment of regional cerebral metabolic abnormalities in single subjects with quantitative and nonquantitative [18F]FDG PET: A clinical validation of statistical parametric mapping. Neuroimage. 9:1999;63-80
26. Theodore W.H., Brooks R., Margolin R., Patronas N., Sato S., Porter R.J., Mansi L., Bairamian D., DiChiro G. Positron emission tomography in generalized seizures. Neurology. 35:1985;684-690
27. Theodore W.H., Rose D., Patronas N., Sato S., Holmes M., Bairaman D., Porter R.J., Di Chiro G., Larson S., Fishbein D. Cerebral glucose metabolism in the Lennox-Gastaut syndrome. Ann. Neurol. 21:1987;14-21
28. Theodore W.H., Sato S., Kufta C.V., Gaillard W.D., Kelley K. FDG-positron emission tomography and invasive EEG: seizure focus detection and surgical outcome. Epilepsia. 38:1997;81-86
29. Theodore W.H. When is positron emission tomography really necessary in epilepsy diagnosis? Curr. Opin. Neurol. 15:2002;191-195
30. Won H.J., Chang K.H., Cheon J.E., Kim H.D., Lee D.S., Han M.H., Kim I.O., Lee S.K., Chung C.K. Comparison of MR imaging with PET and ictal SPECT in 118 patients with intractable epilepsy. Am. J. Neuroradiol. 20:1999;593-599